• 1. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 4. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 5. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948

Hydroxy Flunarizine: A Comprehensive Overview

Hydroxy Flunarizine, also known as Flunarizine hydrochloride, is a compound with the CAS number 87166-81-2. This compound has garnered significant attention in the pharmaceutical industry due to its unique properties and potential therapeutic applications. In this article, we will delve into the latest research findings, chemical characteristics, and clinical implications of Hydroxy Flunarizine.

The chemical structure of Hydroxy Flunarizine is a derivative of flunarizine, a well-known calcium channel blocker. The hydroxylation process introduces a hydroxyl group, which enhances its pharmacokinetic properties and bioavailability. Recent studies have shown that this modification significantly improves the compound's ability to cross the blood-brain barrier, making it a promising candidate for treating central nervous system (CNS) disorders.

One of the most notable applications of Hydroxy Flunarizine is in the treatment of migraines. Clinical trials have demonstrated that this compound exhibits potent anti-migraine effects by inhibiting the activation of trigeminal neurons, which are responsible for pain signaling in migraine attacks. Furthermore, its anti-inflammatory properties make it a potential candidate for managing neuroinflammatory conditions such as multiple sclerosis and Alzheimer's disease.

In recent years, researchers have explored the use of Hydroxy Flunarizine in neuroprotection. Studies conducted on animal models have shown that this compound can reduce oxidative stress and apoptosis in neurons, thereby protecting against neurodegenerative processes. These findings suggest that Hydroxy Flunarizine could be a valuable addition to the arsenal of drugs used in treating conditions like Parkinson's disease and stroke.

The safety profile of Hydroxy Flunarizine has also been extensively studied. Preclinical studies indicate that it has a favorable safety margin with minimal adverse effects at therapeutic doses. However, further research is needed to fully understand its long-term safety and potential for drug interactions.

In terms of manufacturing and development, Hydroxy Flunarizine is synthesized through a multi-step process involving hydroxylation and purification techniques. The production process must adhere to strict quality control measures to ensure the compound's purity and stability. Advanced analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are employed to confirm the compound's identity and integrity.

The global market for compounds like Hydroxy Flunarizine is growing rapidly due to increasing awareness of CNS disorders and the need for effective treatments. Pharmaceutical companies are investing heavily in research and development to explore new indications and formulations for this compound. The future looks promising for Hydroxy Flunarizine, with ongoing clinical trials aiming to expand its therapeutic applications.

In conclusion, Hydroxy Flunarizine, with its unique chemical properties and diverse therapeutic potential, represents a significant advancement in pharmaceutical science. As research continues to uncover new insights into its mechanisms of action and clinical benefits, this compound is poised to play a crucial role in addressing some of the most challenging health conditions of our time.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)